People who are diagnosed with ankylosing spondylitis (AS) are more likely to have had tonsillitis than those without this disease,…
Marisa Wexler MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler MS
Self-harm is more common in people diagnosed with ankylosing spondylitis compared with the general population, a study reveals, suggesting the…
In Italy, Cosentyx (secukinumab) is a cost-saving treatment for ankylosing spondylitis, as well as for psoriatic arthritis and moderate…
High levels of the protein chitotriosidase in the blood are associated with more disease activity in ankylosing spondylitis patients. This protein…
Gender-based differences in fecal metabolites in ankylosing spondylitis patients may provide clues about differences regarding male versus female disease progression.